Optimal lesion preparation before implantation of a Magmaris bioresorbable scaffold in patients with coronary artery stenosis: Rationale, design and methodology of the OPTIMIS study

Autor: Kirstine Nørregaard Hansen, Akiko Maehara, Manijeh Noori, Jens Trøan, Christian Oliver Fallesen, Mikkel Hougaard, Julia Ellert-Gregersen, Karsten Tange Veien, Anders Junker, Henrik Steen Hansen, Jens Flensted Lassen, Lisette Okkels Jensen

Publikováno v: Contemporary Clinical Trials Communications, Vol 38, Iss , Pp 101260- (2024)

Introduction: Percutaneous coronary intervention with implantation of a bioresorbable scaffold (BRS) provide the vessel support for a limited period allowing the vessel to restore normal vasomotion after degradation of the BRS, opposed to treatment w

Externí odkaz: https://doaj.org/article/047f72af8ce04c1d874f75a49335393d

Optical Coherence Tomography- Versus Angiography-Guided Magnesium Bioresorbable Scaffold Implantation in NSTEMI Patients

Autor: Christian Oliver Fallesen, Lisbeth Antonsen, Akiko Maehara, Manijeh Noori, Mikkel Hougaard, Kirstine Nørregaard Hansen, Julia Ellert, Ole Ahlehoff, Karsten Tange Veien, Jens Flensted Lassen, Anders Bo Junker, Henrik Steen Hansen, Lisette Okkels Jensen

Publikováno v: Cardiovascular Revascularization Medicine. 40:101-110

The purpose of a bioresorbable scaffold (BRS) is to provide radial support during coronary healing. In this study, coronary artery healing after optical coherence tomography (OCT)- versus angiography-guided magnesium BRS (MBRS) implantation in patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d9c90279460fd8a60f6101fe56bb03
https://doi.org/10.1016/j.carrev.2021.12.003

Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial

Autor: Kirstine Nørregaard Hansen, Lisette Okkels Jensen, Michael Maeng, Martin Kirk Christensen, Manijeh Noori, Johnny Kahlert, Lars Jakobsen, Anders Junker, Phillip Freeman, Julia Ellert-Gregersen, Bent Raungaard, Christian Juhl Terkelsen, Karsten Tange Veien, Evald Høj Christiansen

Publikováno v: Hansen, K N, Jensen, L O, Maeng, M, Christensen, M K, Noori, M, Kahlert, J, Jakobsen, L, Junker, A, Freeman, P, Ellert-Gregersen, J, Raungaard, B, Terkelsen, C J, Veien, K T & Christiansen, E H 2023, ' Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated with Percutaneous Coronary Intervention : From the SORT OUT VII Trial ', Circulation: Cardiovascular Interventions, vol. 16, no. 1, E012332 . https://doi.org/10.1161/CIRCINTERVENTIONS.122.012332
Hansen, K N, Jensen, L O, Maeng, M, Christensen, M K, Noori, M, Kahlert, J, Jakobsen, L, Junker, A, Freeman, P, Ellert-Gregersen, J, Raungaard, B, Terkelsen, C J, Veien, K T & Christiansen, E H 2023, ' Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention : From the SORT OUT VII Trial ', Circulation. Cardiovascular Interventions, vol. 16, no. 1, e012332 . https://doi.org/10.1161/CIRCINTERVENTIONS.122.012332

Background: Biodegradable polymer drug-eluting stents were developed to improve safety and efficacy outcomes for patients undergoing percutaneous coronary intervention. However, few long-term follow-up efficacy studies are available. The study sought

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a439e95d999b87dee2a3c03f78f0666
https://doi.org/10.1161/circinterventions.122.012332

Early vascular healing after implantation of the polymer-free biolimus-eluting stent or the ultrathin strut biodegradable polymer sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction

Autor: Kirstine N. Hansen, Michael Maeng, Lisbeth Antonsen, Akiko Maehara, Lars Jakobsen, Julia Ellert, Christian J. Terkelsen, Ole Ahlehoff, Troels Thim, Christian O. Fallesen, Manijeh Noori, Karsten T. Veien, Lisette O. Jensen, Evald H. Christiansen

Publikováno v: Hansen, K N, Maeng, M, Antonsen, L, Maehara, A, Jakobsen, L, Ellert, J, Terkelsen, C J, Ahlehoff, O, Thim, T, Fallesen, C O, Noori, M, Veien, K T, Jensen, L O & Christiansen, E H 2022, ' Early vascular healing after implantation of the polymer-free biolimus-eluting stent or the ultrathin strut biodegradable polymer sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction ', Coronary Artery Disease, vol. 33, no. 3, pp. 196-205 . https://doi.org/10.1097/MCA.0000000000001113

OBJECTIVE: To evaluate the difference in early vascular healing between the ultrathin-strut biodegradable-polymer sirolimus-eluting Orsiro stent (O-SES) and the polymer-free biolimus-A9-eluting BioFreedom stent (BF-BES), assessed with optical coheren

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55315893c90a441c845bfb033b35ecff
https://portal.findresearcher.sdu.dk/da/publications/264d85d1-a2a0-4e68-8aa5-b86baae043f0

Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention

Autor: Kirstine N Hansen, Manijeh Noori, Evald H Christiansen, Eskild B Kristiansen, Michael Maeng, Ann Dorthe O Zwisler, Britt Borregaard, Rikke Søgaard, Karsten T Veien, Anders Junker, Lisette Okkels Jensen

Publikováno v: Hansen, K N, Noori, M, Christiansen, E H, Kristiansen, E B, Maeng, M, Zwisler, A D O, Borregaard, B, Søgaard, R, Veien, K T, Junker, A & Jensen, L O 2022, ' Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention ', Diabetes & vascular disease research, vol. 19, no. 4 . https://doi.org/10.1177/14791641221113788

Purpose: The purpose of the study was to investigate the incidence, cause and probability of re-hospitalization within 30 and 365 days after percutaneous coronary intervention (PCI) in patients with diabetes. Method: Between January 2010 and Septembe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837e856f6b63cc5cbee41b2df3c7d0eb
https://doi.org/10.1177/14791641221113788